MyFinsight
Home
About
Contact
glue: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, GLUE has $459,841K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
459,841
359,586
Total stockholders' equity
245,837
268,080
Total liabilities and stockholders' equity
459,841
359,586
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Total property and
equipment, at cost
$53,122K
Prepaid expenses and
other current assets
$5,594K
Other receivables
$4,965K
Marketable securities
$182,915K
Cash and cash
equivalents
$208,343K
Other long-term
assets
$411K
Restricted cash
$4,950K
Operating lease
right-of-use assets
$25,065K
Property and equipment,
net
$27,598K
Total current assets
$401,817K
Less accumulated
depreciation
$25,524K
Total assets
$459,841K
Total liabilities and
stockholders' equity
$459,841K
Total stockholders'
equity
$245,837K
Total liabilities
$214,004K
Accumulated deficit
-$431,079K
Accumulated other
comprehensive loss
-$3,247K
Additional paid-in capital
$680,157K
Operating lease
liability, net of current
$35,927K
Defined benefit plan
liability
$4,740K
Deferred revenue, net of
current
$111,894K
Total current
liabilities
$61,443K
Common stock, 0.0001
par value...
$6K
Current portion of
operating lease liability
$4,241K
Current deferred
revenue
$24,791K
Accrued expenses and
other current...
$17,902K
Accounts payable
$14,509K
Subscribe for Financial Insights
Monte Rosa Therapeutics, Inc. (GLUE)
Monte Rosa Therapeutics, Inc. (GLUE)